Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
clinical trial data
Biotech
Miss for Aridis as antibody flunks phase 3 pneumonia trial
After stopping enrollment early because of COVID-19 and the war in Ukraine, the biotech failed to show AR-301 improves the rate of clinical cure.
Nick Paul Taylor
Jan 26, 2023 8:26am
Chasing Boehringer, Pliant sends stock soaring with IPF data
Jan 23, 2023 6:30am
EpicentRx makes case for cancer toxicity prevention drug
Jan 20, 2023 9:50am
Zymeworks links HER2 bispecific to 84% survival at 18 months
Jan 19, 2023 9:55am
Horizon racks up 2nd win in Sjögren's to claim unique double
Jan 18, 2023 9:30am
NewAmsterdam's Amgen castoff cuts LDL cholesterol in phase 2
Jan 17, 2023 9:15am
